RRM1 and lung adenocarcinoma: In conclusion, the results of the present study revealed that the efficacy of docetaxel/gemcitabine in lung adenocarcinoma patients is associated with RRM1 and RRM2 mRNA expression, thus indicating the importance of tailoring treatment.